Comparison of the effect of rhodium citrate-associated iron oxide nanoparticles on metastatic and non-metastatic breast cancer cells
Abstract Background Nanocarriers have the potential to improve the therapeutic index of currently available drugs by increasing drug efficacy, lowering drug toxicity and achieving steady-state therapeutic levels of drugs over an extended period. The association of maghemite nanoparticles (NPs) with...
Main Authors: | Natalia Lemos Chaves, Danilo Aquino Amorim, Cláudio Afonso Pinho Lopes, Irina Estrela-Lopis, Julia Böttner, Aparecido Ribeiro de Souza, Sônia Nair Báo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-09-01
|
Series: | Cancer Nanotechnology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12645-019-0052-1 |
Similar Items
-
Meme kanseri hücre hatlarında propranolol ve paklitakselin anjiyogenez üzerine etkisi
by: Fatma Şimşek, et al.
Published: (2019-03-01) -
Development of two stable green nanoformulations with potent anticancer properties
by: Ali Ghanbariasad, et al.
Published: (2020-09-01) -
Allium willeanum Holmboe exerts anticancer activities on metastatic breast cancer cells MCF-7 and MDA-MB-231
by: Ovgu Isbilen, et al.
Published: (2021-08-01) -
Hyaluronic Acid-Targeted Stimuli-Sensitive Nanomicelles Co-Encapsulating Paclitaxel and Ritonavir to Overcome Multi-Drug Resistance in Metastatic Breast Cancer and Triple-Negative Breast Cancer Cells
by: Vrinda Gote, et al.
Published: (2021-01-01) -
Detecting heterogeneity in and between breast cancer cell lines
by: Yang Shen, et al.
Published: (2020-02-01)